Patients who experienced a formulary-related rejection of cariprazine for adjunctive treatment of major depressive disorder had significantly higher hospitalization rates than those with approved ...
(A–D) Representative western blots (A) and quantitative analysis (B–D) of LC3B, p62, and beclin 1 after intervention with the DRD3 agonist cariprazine. n = 6. (E, F) Representative immunofluorescence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results